Submit Your Feeds

Business News • PR NewsWire • Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis

Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis
Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis

TOKYO, Nov. 27, 2020 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and FibroGen, Inc. (Nasdaq: FGEN, CEO: Enrique Conterno, "FibroGen") today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) approved EVRENZO®...

View More : https://www.prnewswire.com:443/news-releases/astellas-receives-approval-of-evrenzo-roxadustat-in-japan-for-the-treatment...
Releted News by prnewswire
JinkoSolar to Report Third Quarter 2020 Results on December 7, 2020
EWPG Holding AB: Interim report for the period 1 January - 30 September 2020
Astellas Receives Approval of EVRENZO® (roxadustat) in Japan for the Treatment of Anemia of Chronic Kidney Disease in Adult Patients Not on Dialysis
Re-innovación de la tecnología de imagen térmica - FOTRIC lanza las cámaras térmicas inteligentes 340A y 340M
Neuerfindung der Wärmebildtechnik: FOTRIC bringt intelligente Wärmebildkameras 340A und 340M heraus
La technologie d'imagerie thermique réinventée - FOTRIC lance les imageurs thermiques intelligents 340A et 340M
Home Sitemap Contact Us
© businessNewsNewsNews.com